Marshall H. Woodworth

Direttore Finanziario/CFO presso NEUROBO PHARMACEUTICALS, INC.

Patrimonio netto: 127 620 $ in data 31/05/2024

66 anni

46 relazioni

Health Technology

Consumer Services

Process Industries

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
Hyung-Heon Kim	M	48	NEUROBO PHARMACEUTICALS, INC.	3 anni
Andrew Koven	M	66	NEUROBO PHARMACEUTICALS, INC.	3 anni
D. Strickland	M	77	NEUROBO PHARMACEUTICALS, INC.	2 anni
Mark Glickman	M	58	NEUROBO PHARMACEUTICALS, INC.	1 anni
Michael Salsbury	M	74	NEUROBO PHARMACEUTICALS, INC.	5 anni
Jason Groves	M	53	NEUROBO PHARMACEUTICALS, INC.	5 anni
James Tursi	M	59	NEUROBO PHARMACEUTICALS, INC.	1 anni
Caroline Andersson	F	-	AEROCRINE AB	9 anni
Erling Lennart Johansson	M	69	AEROCRINE AB	9 anni
Eduardo Fracasso	M	64	XERIUM TECHNOLOGIES, INC.	16 anni

Mostra altro

Grafico relazionale

Relazione in diverse aziende

Relazioni precedenti

Nome	Sesso	Età	Società collegate	Collaborazione
June Almenoff	M	67	FURIEX PHARMACEUTICALS INC	4 anni
Scott Myers	M	57	AEROCRINE AB	4 anni
Wendy Dixon	M	68	FURIEX PHARMACEUTICALS INC	4 anni
Stephen R. Light	M	77	XERIUM TECHNOLOGIES, INC.	4 anni
Sriram J. Ramanathan	M	-	Nevakar, Inc. Nevakar, Inc. Pharmaceuticals: MajorHealth Technology Nevakar, Inc. is a specialty injectable pharmaceutical company focused on developing innovative products in injectable and ophthalmic space. The company was founded by Navneet Puri in 2015 and is headquartered in Bridgewater, NJ.	6 anni
Sailash I. Patel	M	-	FURIEX PHARMACEUTICALS INC	-
Michael Colérus	M	62	AEROCRINE AB	15 anni
Staffan Lindstrand	M	62	AEROCRINE AB	15 anni
J. Milner	M	63	XERIUM TECHNOLOGIES, INC.	4 anni
Joseph J. Gurandiano	M	78	XERIUM TECHNOLOGIES, INC.	10 anni
Stephen W. Kaldor	M	62	FURIEX PHARMACEUTICALS INC	4 anni
Thomas Gutierrez	M	75	XERIUM TECHNOLOGIES, INC.	6 anni
David G. Maffucci	M	73	XERIUM TECHNOLOGIES, INC.	2 anni
Stephen Davis	M	63	FURIEX PHARMACEUTICALS INC	1 anni
Paul S. Covington	M	68	FURIEX PHARMACEUTICALS INC	-
Stuart O. Bondurant	M	94	FURIEX PHARMACEUTICALS INC	-
Peter Corr	M	76	FURIEX PHARMACEUTICALS INC	4 anni
Joan Badrinas Ardèvol	M	70	XERIUM TECHNOLOGIES, INC.	7 anni
Jonathan Young	M	54	Braeburn Pharmaceuticals SPRL Braeburn Pharmaceuticals SPRL Medical SpecialtiesHealth Technology Braeburn Pharmaceuticals SPRL develops and commercializes medical products. It’s a pharmaceutical company focused on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain, and schizophrenia. The firm offers Probuohine, CAM2038q1w, CAM2038q4w and Risperdone implant. The company was founded in 2012 and is headquartered in Road Town, British Virgin Islands.	2 anni
Hans Henrik Jacobson	M	51	AEROCRINE AB	2 anni
Ken Marshall	M	-	AEROCRINE AB	-
Morten Pedersen	M	-	AEROCRINE AB	-
Jay Powers	M	62	XERIUM TECHNOLOGIES, INC.	5 anni
Maria Strömme	M	54	AEROCRINE AB	1 anni
John B. Saunders	M	81	XERIUM TECHNOLOGIES, INC.	4 anni
John G. Raos	M	75	XERIUM TECHNOLOGIES, INC.	2 anni
Gail McIntyre	M	61	FURIEX PHARMACEUTICALS INC	4 anni
Henrik Bergentoft	M	50	AEROCRINE AB	2 anni
Donald P. Aiken	M	80	XERIUM TECHNOLOGIES, INC.	4 anni
Nico Hansen	M	55	XERIUM TECHNOLOGIES, INC.	2 anni
John S. Thompson	M	76	XERIUM TECHNOLOGIES, INC.	4 anni
Miguel Quiñonez	M	77	XERIUM TECHNOLOGIES, INC.	7 anni
Cheryl A. Diuguid	F	73	XERIUM TECHNOLOGIES, INC.	3 anni
Anders Murman	M	57	AEROCRINE AB	-
Peter Williamson	M	57	XERIUM TECHNOLOGIES, INC.	4 anni
Bruce Stevens	M	-	FURIEX PHARMACEUTICALS INC	2 anni

Statistiche

Paese	Relazioni	% del totale
Stati Uniti	34	73.91%
Svezia	11	23.91%

Età delle relazioni

Attive

Scorse

Uomo

Donna

Amministratori

Dirigenti

Provenienza delle relazioni